CCN6 (WISP3) as a New Regulator of the Epithelial Phenotype in Breast Cancer

Publisher： Karger

E-ISSN： 1422-6421|185|1-3|95-99

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.185, Iss.1-3, 2007-06, pp. : 95-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3816-3827

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epithelial-Mesenchymal Transition Phenotype for Gastro-Intestinal Cancer

By  

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2942-2955

Bentham Science Publishers

Access to resources Recommend Favorite

New drugs in breast cancer

By Miller William R   Iqbal Shabana  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 975-985

Informa Healthcare

Access to resources Recommend Favorite

Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 6, 2016-05 ,pp. : 486-494

Bentham Science Publishers

Access to resources Recommend Favorite

Colon Cancer: The New Breast Cancer

By Burstein Harold J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 8, 2009-09 ,pp. : 773-773

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite